Literature DB >> 11968483

Selection of antibodies against biotinylated antigens.

Patrick Chames1, Hennie R Hoogenboom, Paula Henderikx.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11968483     DOI： 10.1385/1-59259-240-6:147

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  6 in total

1.  Isolation of scFv fragments specific for monokine induced by interferon-gamma (MIG) using phage display.

Authors:  Edward Eteshola
Journal:  J Immunol Methods       Date:  2010-04-09       Impact factor: 2.303

2.  'In-Format' screening of a novel bispecific antibody format reveals significant potency improvements relative to unformatted molecules.

Authors:  Martin J Scott; Jennifer A Lee; Matthew S Wake; Kelly V Batt; Trevor A Wattam; Ian D Hiles; Thil D Batuwangala; Claire I Ashman; Michael Steward
Journal:  MAbs       Date:  2016-10-27       Impact factor: 5.857

3.  Synthetic antibody libraries focused towards peptide ligands.

Authors:  Christian W Cobaugh; Juan C Almagro; Mark Pogson; Brent Iverson; George Georgiou
Journal:  J Mol Biol       Date:  2008-03-04       Impact factor: 5.469

4.  Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.

Authors:  Chiara Romani; Fabrizio Comper; Elisabetta Bandiera; Antonella Ravaggi; Eliana Bignotti; Renata A Tassi; Sergio Pecorelli; Alessandro D Santin
Journal:  Am J Obstet Gynecol       Date:  2009-05-08       Impact factor: 8.661

5.  Single-Domain Antibodies as Crystallization Chaperones to Enable Structure-Based Inhibitor Development for RBR E3 Ubiquitin Ligases.

Authors:  Yi-Chun Isabella Tsai; Henrik Johansson; David Dixon; Stephen Martin; Chun-Wa Chung; Jane Clarkson; David House; Katrin Rittinger
Journal:  Cell Chem Biol       Date:  2019-12-05       Impact factor: 8.116

6.  Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.

Authors:  Jerry O Conway; Laura J Sherwood; M Thelma Collazo; John A Garza; Andrew Hayhurst
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.